AbbVie to present 30 abstracts demonstrating its leadership in neuroscience, including continued migraine treatment research across the spectrum of the disease, commitment to patients with advanced Parkinson's disease, and new studies in spasticity and cervical dystonia
More than 120 speakers and 5,000 delegates are expected to attend
Additional data across neurological disorders, including Alzheimer’s disease, help advance the scientific understanding of these conditions and the potential impact of early treatment
Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic indications
Despite the challenges of pandemic disruptions, drug developers advance promising therapies for conditions, including Alzheimer's, diabetes and asthma
This is a virtual event and the theme is `Transforming Healthcare beyond Covid’
Revvity is positioning its technologies as a connected engine for discovery
American College of Cardiology and Korean Society of Cardiology convene global experts to address rising cardiometabolic burden
The new unit is expected to serve thousands of patients annually, helping address a critical gap in dialysis access
The upgrade centres on new machinery and advanced technology designed to expand capacity and sharpen turnaround times in increasingly competitive flexible packaging markets.
Subscribe To Our Newsletter & Stay Updated
